Groesbeck Investment Management’s Steris STE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-1,401
Closed -$259K 87
2022
Q4
$259K Buy
1,401
+1
+0.1% +$176 0.43% 68
2022
Q3
$289K Hold
1,400
0.48% 69
2022
Q2
$289K Hold
1,400
0.48% 69
2022
Q1
$338K Sell
1,400
-2,035
-59% -$472K 0.38% 84
2021
Q4
$836K Hold
3,435
1.06% 31
2021
Q3
$702K Sell
3,435
-710
-17% -$152K 0.81% 41
2021
Q2
$855K Buy
4,145
+582
+16% +$117K 1.09% 31
2021
Q1
$679K Buy
3,563
+400
+13% +$74.2K 0.98% 36
2020
Q4
$600K Buy
3,163
+817
+35% +$152K 0.98% 40
2020
Q3
$413K Buy
+2,346
New +$375K 0.77% 51

Other funds holding STE

Groesbeck Investment Management's STE Position: Q1 2023 in Review

Groesbeck Investment Management sold out of Steris (STE) in Q1 2023, closing a stake of 1,401 shares — an estimated $259K sold.

Groesbeck Investment Management first reported a position in STE in Q3 2020 and held it in 10 quarters. The position peaked at $855K in Q2 2021. 621 funds tracked by Wall St. Rank hold STE as of Q1 2023.

  • Groesbeck Investment Management reported no remaining Steris position as of Q1 2023 after selling out during the quarter.
  • Groesbeck Investment Management sold 1,401 Steris shares in Q1 2023, an estimated $259K.
  • Groesbeck Investment Management first reported a position in Steris in Q3 2020 and held it in 10 quarters.
  • Groesbeck Investment Management's Steris position peaked at $855K in Q2 2021.
  • 621 funds tracked by Wall St. Rank held Steris as of Q1 2023.

Based on Groesbeck Investment Management's 13F filing for Q1 2023, filed 26 Apr 2023.